Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 577-582

  Obdeijn, Inge Marie ^a   Winter Warnars, Gonneke A O ^b   Mann, Ritse M ^c   Hooning, Maartje J ^a   Hunink, M G Myriam ^a,d   Tilanus Linthorst, Madeleine M A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

BRCA1 mutation carriers; Breast cancer; Digital mammography; MRI; Radiation induced breast cancer; Screening

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL MAMMOGRAPHY; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION INDUCED BREAST CANCER; RADIATION INDUCED NEOPLASM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION;

ADULT; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENES, BRCA1; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN; YOUNG ADULT;

EID: 84899475783     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2888-8     Document Type: Article

References (21)

1. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for breast and ovarian cancer susceptibility gen BRCA1. Science 266(5182):66-71 (Pubitemid 24345325)
2. Wooster R, Neuhausen SL, Mangion et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(5181):2088-2090 (Pubitemid 24325690)
3. Warner E, Plewes DB, Kimberley A et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound and mammography, and clinical breast examination. JAMA 292(11):1317-1325 (Pubitemid 39223222)
4. MARIBS study group (2005) Screening with magnetic resonance imaging and mammography of a UK population at a high familial risk of breast cancer: a prospective multicentre cohort (MARIBS). Lancet 365:1769-1778
5. Hagen AI, Kvistad KA, Maehle L et al (2007) Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 16(4):267-274
6. Kriege M, Brekelmans CT, Boetes C et al (2004) Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427-437
7. Rijnsburger AJ, Obdeijn IM, Kaas R et al (2010) BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Study. J Clin Oncol 28:5265-5527
8. Sardanelli S, Podo F, Santoro F, for the High Breast Cancer Risk Italian 1 Study (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasound and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study). Invest Radiol 46:94-105
9. Warner E, Hill K, Causer P et al (2011) Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29(13):1664-1669
10. Andrieu N, Easton DF, Chang-Claude J et al (2006) Effect of chest X-ray on the risk of breast cancer among BRCA1/2 mutation carriers in the International carrier Cohort Study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 24(21):3361-3366 (Pubitemid 46638890)
11. Jansen-van der Weide MC, Greuter MJW, Jansen L, Oosterwijk JC, Pijnappel RM, de Bock GH (2010) Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis. Eur Radiol 20:2547-2556
12. Pijpe A, Andrieu N, Easton D, on behalf of GENEPSO, EMBRACE and HEBON et al (2012) Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: a retrospective cohort study (GENE-RAD-RISK). BMJ 6(345):e5660. doi:10.1136/bmj.e5660
13. Pisano ED, Gatsonis C, Hendrick E, Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group et al (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773-1783 (Pubitemid 41549889)
14. NABON NAtionaal Borstkanker Overleg Nederland. Richtlijn mammacarcinoom 2008. Available at http://www.oncoline.nl
15. American College of Radiology (2003) Breast Imaging Reporting and Data System (BI-RADS) Ultrasound, mammography and magnetic resonance atlas. American College of Radiology, Reston
16. Heijnsdijk EAM, Warner E, Gilbert FJ et al (2012) Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21(9):1458-1468
17. Narod A, Lubinski J, Ghadirian P et al (2006) Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case control study. Lancet Oncol 7:402-406
18. Pierce LJ, Strawderman M, Narod S et al (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. JCO 18(19):3360-3369
19. Lakhani SR, van de Vijver MJ, Jacquemier J, for the Breast Cancer Linkage Consortium et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310-2317
20. Brekelmans CTM, Tilanus-Linthorst MMA, Seynaeve C et al (2007) Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 43:867-876 (Pubitemid 46366688)
21. Tilanus-Linthorst MM, Obdeijn IM, Hop WC et al (2007) BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom and Canadian magnetic resonance imaging screening trials. Clin Cancer Res 13:7357-7362